The first 1,000 days describes the period from pre-pregnancy through age 2 years, and is increasingly recognized as a critical period for development of childhood obesity. The overall goal of this study is to test mobile technology-based ecologic momentary interventions (EMIs) to deliver policy-relevant health messages among families living in Washington Heights, a low-income New York City neighborhood with high prevalence of childhood obesity. The proposed research will result in new avenues for reaching families in future interventions to promote healthy beverage intake during the first 1,000 days.
Studying the Impact of Ecological Momentary Interventions on Sugary-Beverage Consumption by Children Through Age 2 in Low-Income Families
Related Research
July 2020
Stories of Success: A Qualitative Examination of Contributors to Excellence in School Drinking Water Access
Drinking water instead of beverages with added sugar can help prevent obesity and cavities and promote overall health. Children spend much of their day in school, where they have variable access to drinking water. In 2010, federal and state law required California public schools to provide free potable water to … More
May 2020
Sugary drink warnings: A meta-analysis of experimental studies
Policymakers worldwide are considering requiring warnings for sugary drinks. A growing number of experimental studies have examined sugary drink warnings’ impacts, but no research to our knowledge has synthesized this literature. To inform ongoing policy debates, this study aimed to identify the effects of sugary drink warnings compared with control … More
April 2020
A Systematic Review of the Effectiveness of Promoting Water Intake to Reduce Sugar-sweetened Beverage Consumption
This study aimed to examine whether promotion of water intake in the general population in and of itself reduces sugar-sweetened beverage (SSB) consumption independent from interventions that target SSBs. Seven electronic databases were systematically searched: PubMed, Embase, PsycInfo, CINAHL Complete, Cochrane Central Register of Controlled Trials, CAB Direct, and Web … More